Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2011-11-08 Interim / Quarterly Rep…
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q3 2011
2011-11-08 English
QUARTERLY REPORT
Interim / Quarterly Report H1 2011
2011-08-09 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 14, 2011, by Sunshine Biopharma, Inc. It reports the entry into a material definitive agreement for clinical trials with the Jewish General Hospital. The content focuses on the announcement of this agreement and includes references to exhibits such as the agreement and a press release. There are no financial statements or detailed financial data presented. The document length is 3795 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2011-06-17 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2011
2011-05-12 English
FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2010
Annual Report FY 2010
2011-03-30 English
FORM 8-K DATED JANUARY 20, 2010
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 20, 2011, reporting the entry into a material definitive agreement (a Research Agreement) with a university. It includes details about the agreement terms, funding conditions, and future options. It also references a press release and includes exhibits. Form 8-K is a current report used to announce significant events or corporate changes, not a full financial report or earnings release. The content focuses on a material agreement and related disclosures, fitting the category of a Regulatory Filing (RNS) as it does not match other more specific categories like capital updates, earnings releases, or management changes. The document length is under 5,000 characters, but it contains substantive information about the agreement, not just an announcement of a report. Therefore, the best classification is Regulatory Filings (RNS).
2011-01-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.